Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 4, 2026

CD4+ T-Lymphocyte Capture Using a Disposable Microfluidic Chip for HIV
12:44

CD4+ T-Lymphocyte Capture Using a Disposable Microfluidic Chip for HIV

Published on: October 1, 2007

A PDMS-based disposable microfluidic sensor for CD4+ lymphocyte counting.

Sara Thorslund1, Rolf Larsson2, Jonas Bergquist3

  • 1Department of Engineering Sciences, Ångström Laboratory, Uppsala University, Box 534, 751 21, Uppsala, Sweden. sara.thorslund@angstrom.uu.se.

Biomedical Microdevices
|June 12, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stress-induced alteration of small extracellular vesicles drives amyloid-beta sequestration and exacerbates Alzheimer's disease pathogenesis.

Alzheimer's research & therapy·2026
Same author

Infrared spectral signatures of plasma-derived small extracellular vesicles reveal diagnostic potential of idiopathic Parkinson's disease detection.

Biochimica et biophysica acta. Biomembranes·2026
Same author

Factors affecting breeding practices and surplus calf management: Producer perspectives from Atlantic Canada.

Journal of dairy science·2026
Same author

Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US.

Journal of the American College of Cardiology·2025
Same author

FTIR spectroscopy of plasma exosomes reveals distinct lipidomic and proteomic signatures for early Alzheimer's disease detection.

Clinica chimica acta; international journal of clinical chemistry·2025
Same author

Assessment of chemical methods in the extraction of spore surface layers in <i>Clostridioides difficile</i> spores.

mSphere·2025
Same journal

A pump-free gravity-driven microfluidic chip for rapid RPA-LFS-based detection of Magnaporthe oryzae AvrPi9 gene.

Biomedical microdevices·2026
Same journal

Mechanotherapeutic biomaterials: Overcoming physical barriers to enhance intratumoral drug delivery in solid tumours.

Biomedical microdevices·2026
Same journal

Reversibly-sealable microfluidic platform for multi-molecule gradient delivery to large adherent cell cultures.

Biomedical microdevices·2026
Same journal

3D printed chip as platform to vascularize hiPSCs-derived kidney organoids.

Biomedical microdevices·2026
Same journal

Ingestible smart capsules: from engineering innovation to GI drug delivery.

Biomedical microdevices·2026
Same journal

An inexpensive, portable, refrigeration-free, ready-to-use microfluidic device for real-time multiplexed molecular detection of HIV, HBV, and HCV.

Biomedical microdevices·2026
See all related articles

A new CD4+ lymphocyte sensor using capillary action was developed. Dilution media significantly impacts cell counts, highlighting the need for controlled testing in clinical settings.

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Microfluidics

Background:

  • Accurate CD4+ lymphocyte counts are crucial for managing immune deficiencies.
  • Existing methods like flow cytometry can be complex and require specialized equipment.
  • Development of portable, user-friendly diagnostic tools is needed.

Purpose of the Study:

  • To develop and evaluate a novel microfluidic sensor for CD4+ lymphocyte quantification.
  • To assess the sensor's performance against standard flow cytometry.
  • To investigate the impact of sample preparation and dilution media on sensor accuracy.

Main Methods:

  • Fabrication of a PDMS-based micropillar structured sensor.
  • Surface modification for biocompatibility and CD4+ cell capture.

More Related Videos

Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles
11:54

Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles

Published on: March 13, 2017

Comprehensive &amp; Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Related Experiment Videos

Last Updated: Jul 4, 2026

CD4+ T-Lymphocyte Capture Using a Disposable Microfluidic Chip for HIV
12:44

CD4+ T-Lymphocyte Capture Using a Disposable Microfluidic Chip for HIV

Published on: October 1, 2007

Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles
11:54

Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles

Published on: March 13, 2017

Comprehensive &amp; Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

  • Capillary-driven filling and rinsing without external pumps.
  • Comparison of sensor results with flow cytometry using whole blood and diluted samples.
  • Main Results:

    • The developed sensor demonstrated acceptable agreement (79%) with flow cytometry for whole blood.
    • Diluting blood in PBS buffer led to increased cell counts due to shear-induced migration.
    • The choice of diluent (plasma, PBS with glycerol/albumin) significantly altered cell behavior.
    • Importance of controlling dilution media for capillary-driven microfluidic devices was confirmed.

    Conclusions:

    • The capillary-driven microfluidic sensor shows promise for CD4+ lymphocyte counting.
    • Careful consideration of dilution media is essential to mitigate cell migration artifacts.
    • Further validation with clinically relevant low CD4+ counts is required.